Trials / Completed
CompletedNCT00174330
Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia
A Multi-Center, Randomized, Open-Label Study To Evaluate Efficacy And Safety Of Dual Therapy With Atorvastatin Plus Amlodipine When Compared Amlodipine Therapy Alone In The Treatment Of Subjects With Concurrent Hyperlipidemia And Hypertension.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 330 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate efficacy of the dual therapy of atorvastatin + amlodipine vs. amlodipine alone .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | atorvastatin | |
| DRUG | amlodipine |
Timeline
- Start date
- 2005-05-01
- Completion
- 2006-02-01
- First posted
- 2005-09-15
- Last updated
- 2021-01-27
Locations
15 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00174330. Inclusion in this directory is not an endorsement.